Physical Confirmation and Mapping of Overlapping Rat Mammary Carcinoma Susceptibility QTLs, Mcs2 and Mcs6

Only a portion of the estimated heritability of breast cancer susceptibility has been explained by individual loci. Comparative genetic approaches that first use an experimental organism to map susceptibility QTLs are unbiased methods to identify human orthologs to target in human population-based genetic association studies. Here, overlapping rat mammary carcinoma susceptibility (Mcs) predicted QTLs, Mcs6 and Mcs2, were physically confirmed and mapped to identify the human orthologous region. To physically confirm Mcs6 and Mcs2, congenic lines were established using the Wistar-Furth (WF) rat strain, which is susceptible to developing mammary carcinomas, as the recipient (genetic background) and either Wistar-Kyoto (WKy, Mcs6) or Copenhagen (COP, Mcs2), which are resistant, as donor strains. By comparing Mcs phenotypes of WF.WKy congenic lines with distinct segments of WKy chromosome 7 we physically confirmed and mapped Mcs6 to ∼33 Mb between markers D7Rat171 and gUwm64-3. The predicted Mcs2 QTL was also physically confirmed using segments of COP chromosome 7 introgressed into a susceptible WF background. The Mcs6 and Mcs2 overlapping genomic regions contain multiple annotated genes, but none have a clear or well established link to breast cancer susceptibility. Igf1 and Socs2 are two of multiple potential candidate genes in Mcs6. The human genomic region orthologous to rat Mcs6 is on chromosome 12 from base positions 71,270,266 to 105,502,699. This region has not shown a genome-wide significant association to breast cancer risk in pun studies of breast cancer susceptibility.

[1]  M. Waters,et al.  Suppressor of cytokine signalling gene expression is elevated in breast carcinoma , 2003, British Journal of Cancer.

[2]  Andrew W Roddam,et al.  Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies , 2010, The Lancet. Oncology.

[3]  J. Russo,et al.  Atlas and Histologic Classification of Tumors of the Rat Mammary Gland , 2000, Journal of Mammary Gland Biology and Neoplasia.

[4]  Montserrat Garcia-Closas,et al.  Genetic susceptibility to breast cancer , 2010, Molecular oncology.

[5]  D. Santini,et al.  Suppressor of cytokine signalling 2 (SOCS-2) expression in breast carcinoma , 2005, Journal of Clinical Pathology.

[6]  F. Révillion,et al.  Favorable prognostic value of SOCS2 and IGF-I in breast cancer , 2007, BMC Cancer.

[7]  K. Sjögren,et al.  Estrogen inhibits GH signaling by suppressing GH-induced JAK2 phosphorylation, an effect mediated by SOCS-2 , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[8]  J. Chang-Claude,et al.  Polymorphisms of genes coding for insulin-like growth factor 1 and its major binding proteins, circulating levels of IGF-I and IGFBP-3 and breast cancer risk: results from the EPIC study , 2006, British Journal of Cancer.

[9]  C. Plass,et al.  SLC5A8, a sodium transporter, is a tumor suppressor gene silenced by methylation in human colon aberrant crypt foci and cancers , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[10]  Nicholas J Wareham,et al.  IGF1 and IGFBP3 tagging polymorphisms are associated with circulating levels of IGF1, IGFBP3 and risk of breast cancer. , 2006, Human molecular genetics.

[11]  Mary Shimoyama,et al.  The Rat Genome Database, update 2007—Easing the path from disease to data and back again , 2006, Nucleic Acids Res..

[12]  M. Newton,et al.  Genetic loci controlling breast cancer susceptibility in the Wistar-Kyoto rat. , 2001, Genetics.

[13]  J. Visvader,et al.  Socs2 and elf5 mediate prolactin-induced mammary gland development. , 2006, Molecular endocrinology.

[14]  J. Papp,et al.  Linkage of posterior amorphous corneal dystrophy to chromosome 12q21.33 and exclusion of coding region mutations in KERA, LUM, DCN, and EPYC. , 2010, Investigative ophthalmology & visual science.

[15]  A. Hart,et al.  Most Lung and Colon Cancer Susceptibility Genes Are Pair-Wise Linked in Mice, Humans and Rats , 2011, PloS one.

[16]  B. Datta.  Roles of P67/MetAP2 as a tumor suppressor. , 2009, Biochimica et biophysica acta.

[17]  A. Neugut,et al.  IGF1 CA repeat polymorphisms, lifestyle factors and breast cancer risk in the Long Island Breast Cancer Study Project. , 2006, Carcinogenesis.

[18]  H. Lan,et al.  Physical evidence of Mcs5, a QTL controlling mammary carcinoma susceptibility, in congenic rats. , 2003, Carcinogenesis.

[19]  John P A Ioannidis,et al.  A compendium of genome-wide associations for cancer: critical synopsis and reappraisal. , 2010, Journal of the National Cancer Institute.

[20]  E. Madrigal-Bujaidar,et al.  Genetic expression profiles and chromosomal alterations in sporadic breast cancer in Mexican women. , 2006, Cancer genetics and cytogenetics.

[21]  J. Bonneterre,et al.  Insulin-like growth factor 1 receptors (IGF1-R) and IGF1 in human breast tumors , 1990, The Journal of Steroid Biochemistry and Molecular Biology.

[22]  J. Shull.  The rat oncogenome: comparative genetics and genomics of rat models of mammary carcinogenesis. , 2007, Breast disease.

[23]  D. Duggan,et al.  Recent developments in genomewide association scans: a workshop summary and review. , 2005, American journal of human genetics.

[24]  M A Newton,et al.  Genetic identification of multiple loci that control breast cancer susceptibility in the rat. , 1998, Genetics.

[25]  W. Willett,et al.  Eighteen insulin-like growth factor pathway genes, circulating levels of IGF-I and its binding protein, and risk of prostate and breast cancer. , 2010, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[26]  Alison M. Dunning,et al.  Rat Mcs5a is a compound quantitative trait locus with orthologous human loci that associate with breast cancer risk , 2007, Proceedings of the National Academy of Sciences.

[27]  Daniel L Gillen,et al.  Genetic variation in insulin-like growth factor signaling genes and breast cancer risk among BRCA1 and BRCA2 carriers , 2009, Breast Cancer Research.

[28]  M. Pike,et al.  IGF-1, IGFBP-1, and IGFBP-3 Polymorphisms Predict Circulating IGF Levels but Not Breast Cancer Risk: Findings from the Breast and Prostate Cancer Cohort Consortium (BPC3) , 2008, PloS one.

[29]  W. Jiang,et al.  Higher expression levels of SOCS 1,3,4,7 are associated with earlier tumour stage and better clinical outcome in human breast cancer , 2010, BMC Cancer.

[30]  Tom H. Pringle,et al.  The human genome browser at UCSC. , 2002, Genome research.

[31]  G. Secreto,et al.  ENDOGENOUS HORMONES AND BREAST CANCER , 1998 .